Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DKF-306 in Patients With Periodontal Diseases
NCT05188924Phase 4Unknown
- Sponsor
- Dongkook Pharmaceutical
- Start
- May 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of DKF-306 in Periodontal disease (PD), sponsored by Dongkook Pharmaceutical. Status: unknown.
02
Drugs
DKF-306
03
Conditions
Periodontal disease (PD)
Beyond the preview
Go deeper on NCT05188924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188924.